Status:
ACTIVE_NOT_RECRUITING
A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery
Lead Sponsor:
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chest tubes are routinely required after surgical procedures for lung cancer. This device is a flexible plastic tube that is inserted through the chest wall to remove air or fluid from around your lun...
Eligibility Criteria
Inclusion
- Patients who are undergoing lobectomy or segmentectomy
- Patients undergoing wedge resection to diagnose, or as definitive therapy for a lung nodule/cancer.
- Able to understand and sign consent
Exclusion
- Patients undergoing pneumonectomy or bilobectomy
- Patients undergoing resection for inflammatory conditions such as aspergillosis
- Patients undergoing diagnostic wedge resection for interstitial lung disease
- Patients undergoing redo-VATS or thoracotomy on the same side as current planned resection
- Patients found to have a "frozen chest" at the time of surgery, requiring extensive adhesiolysis,
- Patients who are discovered to have metastatic disease during the operation, so that resection is no longer indicated.
- Patients where a clinical decision to place more than one chest-tube is made
Key Trial Info
Start Date :
February 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04913415
Start Date
February 23 2021
End Date
August 1 2024
Last Update
April 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States, 15212